Replies to post #176 on Adaptimmune Therapeutics PLC (ADAP)

[jondoeuk]

335: Next-Generation, Inducible IL-7-Expressing, Tumor-Infiltrating Lymphocytes by Lentiviral Vector Genetic Modification for Clinical Application https://annualmeeting.asgct.org/abstracts/abstract-details?abstractId=1289

385: IL-7 and CCL19 Expression in Specific Peptide Enhanced Affinity Receptor T-cells Targeting MAGE-A4 Display Improved Survival and Ability to Induce Migration of Immune Cells https://annualmeeting.asgct.org/abstracts/abstract-details?abstractId=1335

1168: A Novel Flow Cytometry Method for Rapid Assessment of Lentiviral Detection https://annualmeeting.asgct.org/abstracts/abstract-details?abstractId=2064